Penetration of linezolid and tedizolid in cerebrospinal fluid of mouse and impact of blood–brain barrier disruption
Abstract Penetration of antimicrobial treatments into the cerebrospinal fluid is essential to successfully treat infections of the central nervous system. This penetration is hindered by different barriers, including the blood–brain barrier, which is the most impermeable. However, inflammation may l...
Saved in:
| Main Authors: | Marin Lahouati, Mélanie Oudart, Philippe Alzieu, Candice Chapouly, Antoine Petitcollin, Fabien Xuereb |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Clinical and Translational Science |
| Online Access: | https://doi.org/10.1111/cts.70100 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COMPARISON OF THE CLINICAL ACTIVITY OF TWO OXAZOLIDINONES – LINEZOLID AND TEDIZOLIDE: UNJUSTIFIED EXPECTATIONS
by: N. V. Dmitrieva, et al.
Published: (2018-11-01) -
Vancomycin versus linezolid for treatment of staphylococcal-associated central nervous system infections
by: Marin Lahouati, et al.
Published: (2025-03-01) -
Linezolid and tedizolid adverse effects: a review on serotonin syndrome, myelosuppression, neuropathies, and lactic acidosis
by: Adam Greenfield, et al.
Published: (2025-01-01) -
Study on the Efficacy and Safety of Tedizolid in Japanese Patients
by: Kazuhiro Ishikawa, et al.
Published: (2024-12-01) -
Mutations in the transcriptional regulator MAB_2885 confer tedizolid and linezolid resistance through the MmpS-MmpL efflux pump MAB_2302-MAB_2303 in Mycobacterium abscessus.
by: Huiyun Zhang, et al.
Published: (2025-05-01)